Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Kenter

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Human Immunology|June 11, 1999
HLA and susceptibility to cervical neoplasiaE J Krul, R F Schipper, G M Schreuder, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 6, 2001
[Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence]B W Hellebrekers, A H Zwinderman, G G Kenter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1989
Carcinoma of the uterine cervix stage I and IIA: results of surgical treatment: complications, recurrence and survivalG G Kenter, A C Ansink, A P Heintz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 26, 2000
The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinomaG G Kenter, B W Hellebrekers, K H Zwinderman, et al.
British Journal of Cancer|April 9, 2009
Expression of endoglin (CD105) in cervical cancerH J Zijlmans, G J Fleuren, S Hazelbag, et al.
European Journal of Gynaecological Oncology|April 26, 2018
New biomarkers in epithelial ovarian cancer: needed or redundant?A Stiekema, C M Korse, N K Aaronson, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 10, 2003
[Recommendations for the management of women with an increased genetic risk of gynaecological cancer]R H M Verheijen, H Boonstra, F H Menko, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2019
Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelinesR F M Vermeulen, C M Korse, G G Kenter, et al.
Gynecologic Oncology|January 15, 2014
A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancerA Stiekema, C A R Lok, G G Kenter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisionsK N Gaarenstroom, G G Kenter, J B Trimbos, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Human Immunology|June 11, 1999
HLA and susceptibility to cervical neoplasiaE J Krul, R F Schipper, G M Schreuder, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 6, 2001
[Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence]B W Hellebrekers, A H Zwinderman, G G Kenter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1989
Carcinoma of the uterine cervix stage I and IIA: results of surgical treatment: complications, recurrence and survivalG G Kenter, A C Ansink, A P Heintz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 26, 2000
The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinomaG G Kenter, B W Hellebrekers, K H Zwinderman, et al.
British Journal of Cancer|April 9, 2009
Expression of endoglin (CD105) in cervical cancerH J Zijlmans, G J Fleuren, S Hazelbag, et al.
European Journal of Gynaecological Oncology|April 26, 2018
New biomarkers in epithelial ovarian cancer: needed or redundant?A Stiekema, C M Korse, N K Aaronson, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 10, 2003
[Recommendations for the management of women with an increased genetic risk of gynaecological cancer]R H M Verheijen, H Boonstra, F H Menko, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2019
Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelinesR F M Vermeulen, C M Korse, G G Kenter, et al.
Gynecologic Oncology|January 15, 2014
A predictive model combining human epididymal protein 4 and radiologic features for the diagnosis of ovarian cancerA Stiekema, C A R Lok, G G Kenter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisionsK N Gaarenstroom, G G Kenter, J B Trimbos, et al.
Pageof 9